These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [Abstract] [Full Text] [Related]
3. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women. Dartell MA, Rasch V, Iftner T, Kahesa C, Mwaiselage JD, Junge J, Gernow A, Ejlersen SF, Munk C, Kjaer SK. Int J Cancer; 2014 Aug 15; 135(4):896-904. PubMed ID: 24391021 [Abstract] [Full Text] [Related]
8. Lower cost strategies for triage of human papillomavirus DNA-positive women. Qiao YL, Jeronimo J, Zhao FH, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE. Int J Cancer; 2014 Jun 15; 134(12):2891-901. PubMed ID: 24248915 [Abstract] [Full Text] [Related]
10. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. Segondy M, Kelly H, Magooa MP, Djigma F, Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Michelow P, Doutre S, Clavero O, Chikandiwa A, Sawadogo B, Didelot MN, Costes V, Méda N, Delany-Moretlwe S, Mayaud P. Br J Cancer; 2016 Aug 09; 115(4):425-30. PubMed ID: 27434037 [Abstract] [Full Text] [Related]
13. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women. Baldur-Felskov B, Mwaiselage J, Faber MT, Kjaerem M, de la Cour CD, Munk C, Kahesa C, Iftner T, Rasch V, Kjaer SK. Trop Med Int Health; 2019 Feb 09; 24(2):229-237. PubMed ID: 30444556 [Abstract] [Full Text] [Related]
15. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Dong L, Wang MZ, Zhao XL, Feng RM, Hu SY, Zhang Q, Smith JS, Qiao YL, Zhao FH. Gynecol Oncol; 2018 Jan 09; 148(1):103-110. PubMed ID: 29169614 [Abstract] [Full Text] [Related]
16. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand. Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Srisomboon J, Intaraphet S, Siriaunkgul S. PLoS One; 2016 Jan 09; 11(6):e0158184. PubMed ID: 27336913 [Abstract] [Full Text] [Related]
17. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania. Katanga J, Kjaer SK, Manongi R, Pembe AB, Iftner T, Waldstrom M, Mwaiselage J, Rasch V. Acta Obstet Gynecol Scand; 2021 Apr 09; 100(4):786-793. PubMed ID: 33497480 [Abstract] [Full Text] [Related]
18. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China. Rezhake R, Chen F, Hu SY, Zhao XL, Zhang X, Cao J, Qiao YL, Zhao FH, Arbyn M. Int J Cancer; 2020 Oct 15; 147(8):2053-2064. PubMed ID: 32249409 [Abstract] [Full Text] [Related]
19. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC, HERMES study group. PLoS One; 2015 Oct 15; 10(3):e0119755. PubMed ID: 25793281 [Abstract] [Full Text] [Related]